

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 7.67310390 |
| 2 | central nervous system myelination (GO:0022010) | 7.67310390 |
| 3 | astrocyte development (GO:0014002) | 5.49456593 |
| 4 | myelin maintenance (GO:0043217) | 5.46676881 |
| 5 | cellular response to cadmium ion (GO:0071276) | 5.44767535 |
| 6 | ensheathment of neurons (GO:0007272) | 5.43523605 |
| 7 | axon ensheathment (GO:0008366) | 5.43523605 |
| 8 | myelination (GO:0042552) | 5.41440610 |
| 9 | adhesion of symbiont to host (GO:0044406) | 5.23619170 |
| 10 | fatty acid elongation (GO:0030497) | 5.18916600 |
| 11 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 5.04986890 |
| 12 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.75344071 |
| 13 | gonadal mesoderm development (GO:0007506) | 4.67124222 |
| 14 | C21-steroid hormone biosynthetic process (GO:0006700) | 4.62647772 |
| 15 | estrogen biosynthetic process (GO:0006703) | 4.52741339 |
| 16 | peripheral nervous system axon ensheathment (GO:0032292) | 4.52083177 |
| 17 | myelination in peripheral nervous system (GO:0022011) | 4.52083177 |
| 18 | COPI coating of Golgi vesicle (GO:0048205) | 4.49015400 |
| 19 | Golgi transport vesicle coating (GO:0048200) | 4.49015400 |
| 20 | virion attachment to host cell (GO:0019062) | 4.45293103 |
| 21 | adhesion of symbiont to host cell (GO:0044650) | 4.45293103 |
| 22 | NADPH regeneration (GO:0006740) | 4.39125924 |
| 23 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.29313391 |
| 24 | fusion of sperm to egg plasma membrane (GO:0007342) | 4.25984272 |
| 25 | extracellular fibril organization (GO:0043206) | 4.24354440 |
| 26 | alpha-linolenic acid metabolic process (GO:0036109) | 4.20734311 |
| 27 | pentose-phosphate shunt (GO:0006098) | 4.18366096 |
| 28 | creatine metabolic process (GO:0006600) | 4.09373452 |
| 29 | polyketide metabolic process (GO:0030638) | 4.07979151 |
| 30 | doxorubicin metabolic process (GO:0044598) | 4.07979151 |
| 31 | daunorubicin metabolic process (GO:0044597) | 4.07979151 |
| 32 | very long-chain fatty acid metabolic process (GO:0000038) | 4.06252595 |
| 33 | positive regulation of male gonad development (GO:2000020) | 3.86781269 |
| 34 | Leydig cell differentiation (GO:0033327) | 3.78598013 |
| 35 | fibril organization (GO:0097435) | 3.76780333 |
| 36 | sex determination (GO:0007530) | 3.74053848 |
| 37 | response to lead ion (GO:0010288) | 3.73507179 |
| 38 | barbed-end actin filament capping (GO:0051016) | 3.72559789 |
| 39 | response to follicle-stimulating hormone (GO:0032354) | 3.67424414 |
| 40 | glomerular basement membrane development (GO:0032836) | 3.64633811 |
| 41 | androgen biosynthetic process (GO:0006702) | 3.58160221 |
| 42 | eye photoreceptor cell differentiation (GO:0001754) | 3.54491753 |
| 43 | photoreceptor cell differentiation (GO:0046530) | 3.54491753 |
| 44 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.53381276 |
| 45 | platelet aggregation (GO:0070527) | 3.49953045 |
| 46 | cyclooxygenase pathway (GO:0019371) | 3.48010254 |
| 47 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.45456922 |
| 48 | thrombin receptor signaling pathway (GO:0070493) | 3.38510939 |
| 49 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.37244688 |
| 50 | type B pancreatic cell proliferation (GO:0044342) | 3.34594041 |
| 51 | platelet degranulation (GO:0002576) | 3.33666385 |
| 52 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.32314887 |
| 53 | negative regulation of protein localization to cell surface (GO:2000009) | 3.32135856 |
| 54 | regulation of male gonad development (GO:2000018) | 3.29730166 |
| 55 | glucose catabolic process (GO:0006007) | 3.29208430 |
| 56 | beta-amyloid metabolic process (GO:0050435) | 3.26268455 |
| 57 | oligodendrocyte differentiation (GO:0048709) | 3.26152519 |
| 58 | amyloid precursor protein catabolic process (GO:0042987) | 3.24507563 |
| 59 | estrogen metabolic process (GO:0008210) | 3.24297173 |
| 60 | amyloid precursor protein metabolic process (GO:0042982) | 3.21657312 |
| 61 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.21573603 |
| 62 | response to lipoprotein particle (GO:0055094) | 3.21515824 |
| 63 | piRNA metabolic process (GO:0034587) | 3.20696379 |
| 64 | cellular response to cholesterol (GO:0071397) | 3.19943465 |
| 65 | protein retention in ER lumen (GO:0006621) | 3.17226369 |
| 66 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.15137058 |
| 67 | positive regulation of pseudopodium assembly (GO:0031274) | 3.13985779 |
| 68 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.12037015 |
| 69 | Sertoli cell development (GO:0060009) | 3.11903317 |
| 70 | cholesterol biosynthetic process (GO:0006695) | 3.10880617 |
| 71 | blood coagulation, intrinsic pathway (GO:0007597) | 3.09154547 |
| 72 | glomerular filtration (GO:0003094) | 3.06086394 |
| 73 | pinocytosis (GO:0006907) | 3.05563098 |
| 74 | regulation of gonadotropin secretion (GO:0032276) | 3.02136287 |
| 75 | response to methylmercury (GO:0051597) | 3.01373892 |
| 76 | renal filtration (GO:0097205) | 3.00059449 |
| 77 | plasma membrane fusion (GO:0045026) | 2.99051197 |
| 78 | negative regulation of stress fiber assembly (GO:0051497) | 2.98275256 |
| 79 | cell adhesion mediated by integrin (GO:0033627) | 2.96755198 |
| 80 | stress fiber assembly (GO:0043149) | 2.95797802 |
| 81 | skin morphogenesis (GO:0043589) | 2.94984924 |
| 82 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.91621071 |
| 83 | regulation of platelet aggregation (GO:0090330) | 2.90168066 |
| 84 | asymmetric protein localization (GO:0008105) | 2.89192910 |
| 85 | NADP metabolic process (GO:0006739) | 2.87840472 |
| 86 | blood vessel maturation (GO:0001955) | 2.87312593 |
| 87 | pentose metabolic process (GO:0019321) | 2.87078244 |
| 88 | response to leptin (GO:0044321) | 2.87066573 |
| 89 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.86365748 |
| 90 | L-serine transport (GO:0015825) | 2.85471713 |
| 91 | cellular response to growth hormone stimulus (GO:0071378) | 2.85302805 |
| 92 | progesterone metabolic process (GO:0042448) | 2.83706628 |
| 93 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.83176945 |
| 94 | membrane tubulation (GO:0097320) | 2.83123175 |
| 95 | membrane protein ectodomain proteolysis (GO:0006509) | 2.82829687 |
| 96 | regulation of cholesterol esterification (GO:0010872) | 2.81793372 |
| 97 | glial cell development (GO:0021782) | 2.81780906 |
| 98 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.79554590 |
| 99 | sterol biosynthetic process (GO:0016126) | 2.78390469 |
| 100 | cellular response to gonadotropin stimulus (GO:0071371) | 2.78128538 |
| 101 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.77837921 |
| 102 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.77716190 |
| 103 | membrane invagination (GO:0010324) | 2.76894744 |
| 104 | acyl-CoA biosynthetic process (GO:0071616) | 2.76565648 |
| 105 | thioester biosynthetic process (GO:0035384) | 2.76565648 |
| 106 | macroautophagy (GO:0016236) | 2.76513332 |
| 107 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.75663180 |
| 108 | L-serine metabolic process (GO:0006563) | 2.73988133 |
| 109 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.73978287 |
| 110 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.73745827 |
| 111 | phagocytosis, recognition (GO:0006910) | 2.73467188 |
| 112 | cellular response to leptin stimulus (GO:0044320) | 2.73251418 |
| 113 | apical protein localization (GO:0045176) | 2.72213882 |
| 114 | triglyceride catabolic process (GO:0019433) | 2.71871163 |
| 115 | linoleic acid metabolic process (GO:0043651) | 2.71368701 |
| 116 | tricarboxylic acid metabolic process (GO:0072350) | 2.70940348 |
| 117 | glucose 6-phosphate metabolic process (GO:0051156) | 2.70835572 |
| 118 | ovulation cycle (GO:0042698) | 2.70537123 |
| 119 | C21-steroid hormone metabolic process (GO:0008207) | 2.70434912 |
| 120 | anatomical structure regression (GO:0060033) | 2.70215188 |
| 121 | regulation of platelet activation (GO:0010543) | 2.69924755 |
| 122 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.68390980 |
| 123 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.67729726 |
| 124 | glial cell proliferation (GO:0014009) | 2.67482076 |
| 125 | negative regulation of platelet activation (GO:0010544) | 2.66176581 |
| 126 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.65258894 |
| 127 | lens fiber cell development (GO:0070307) | 2.64499402 |
| 128 | neutral lipid catabolic process (GO:0046461) | 2.64124779 |
| 129 | acylglycerol catabolic process (GO:0046464) | 2.64124779 |
| 130 | regulation of cholesterol metabolic process (GO:0090181) | 2.62989876 |
| 131 | protein maturation by protein folding (GO:0022417) | 2.62184362 |
| 132 | positive regulation of actin filament depolymerization (GO:0030836) | 2.61585993 |
| 133 | positive regulation of hemostasis (GO:1900048) | 2.61139928 |
| 134 | positive regulation of blood coagulation (GO:0030194) | 2.61139928 |
| 135 | nephron tubule formation (GO:0072079) | 2.60493237 |
| 136 | low-density lipoprotein particle clearance (GO:0034383) | 2.59871305 |
| 137 | adenosine receptor signaling pathway (GO:0001973) | 2.59636292 |
| 138 | sex differentiation (GO:0007548) | 2.59480522 |
| 139 | positive regulation of coagulation (GO:0050820) | 2.59252361 |
| 140 | positive regulation of macrophage cytokine production (GO:0060907) | 2.57057321 |
| 141 | regulation of pseudopodium assembly (GO:0031272) | 2.56953360 |
| 142 | phagocytosis, engulfment (GO:0006911) | 2.56087880 |
| 143 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.54330890 |
| 144 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.53694075 |
| 145 | positive regulation of gliogenesis (GO:0014015) | 2.53575996 |
| 146 | positive regulation of extracellular matrix organization (GO:1903055) | 2.52881108 |
| 147 | enteric nervous system development (GO:0048484) | 2.52298108 |
| 148 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.51488120 |
| 149 | hemoglobin metabolic process (GO:0020027) | 2.50513680 |
| 150 | ethanol oxidation (GO:0006069) | 2.49869986 |
| 151 | regulation of collateral sprouting (GO:0048670) | 2.49718748 |
| 152 | cholesterol metabolic process (GO:0008203) | 2.48479399 |
| 153 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.48261025 |
| 154 | protein carboxylation (GO:0018214) | 2.48261025 |
| 155 | positive regulation of astrocyte differentiation (GO:0048711) | 2.48219569 |
| 156 | response to nitrosative stress (GO:0051409) | 2.47831099 |
| 157 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.46595042 |
| 158 | positive regulation of glial cell differentiation (GO:0045687) | 2.46580605 |
| 159 | serine transport (GO:0032329) | 2.45989480 |
| 160 | positive regulation of receptor recycling (GO:0001921) | 2.45943776 |
| 161 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.45866506 |
| 162 | sterol metabolic process (GO:0016125) | 2.45858099 |
| 163 | keratan sulfate catabolic process (GO:0042340) | 2.44693288 |
| 164 | peptide catabolic process (GO:0043171) | 2.44568492 |
| 165 | regulation of lipoprotein metabolic process (GO:0050746) | 2.44565050 |
| 166 | sterol catabolic process (GO:0016127) | 2.44248185 |
| 167 | cholesterol catabolic process (GO:0006707) | 2.44248185 |
| 168 | response to misfolded protein (GO:0051788) | 2.43801033 |
| 169 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.43494981 |
| 170 | extracellular matrix assembly (GO:0085029) | 2.42425482 |
| 171 | glucocorticoid biosynthetic process (GO:0006704) | 2.42275127 |
| 172 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.41469522 |
| 173 | lipoxygenase pathway (GO:0019372) | 2.40749527 |
| 174 | proline biosynthetic process (GO:0006561) | 2.40210837 |
| 175 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.39193117 |
| 176 | glycoside metabolic process (GO:0016137) | 2.37241894 |
| 177 | angiogenesis involved in wound healing (GO:0060055) | 2.37183465 |
| 178 | xenobiotic catabolic process (GO:0042178) | 2.35223587 |
| 179 | homotypic cell-cell adhesion (GO:0034109) | 2.32096311 |
| 180 | dermatan sulfate biosynthetic process (GO:0030208) | 2.31017084 |
| 181 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.30494622 |
| 182 | regulation of early endosome to late endosome transport (GO:2000641) | 2.30074139 |
| 183 | endothelium development (GO:0003158) | 2.29327577 |
| 184 | fibrinolysis (GO:0042730) | 2.28808456 |
| 185 | regulation of extracellular matrix disassembly (GO:0010715) | 2.28707544 |
| 186 | basement membrane organization (GO:0071711) | 2.28381866 |
| 187 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.27791349 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.59379620 |
| 2 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.08176319 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.03079944 |
| 4 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.99494989 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.85962036 |
| 6 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.61401698 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.52583185 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.48046105 |
| 9 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.28661816 |
| 10 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.17449977 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.13692075 |
| 12 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.05496035 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.93330763 |
| 14 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.91056800 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.90815938 |
| 16 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.75411434 |
| 17 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.74539124 |
| 18 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.72981495 |
| 19 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.71923976 |
| 20 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.68519196 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.65286655 |
| 22 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.61423505 |
| 23 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.59787919 |
| 24 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.57293168 |
| 25 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.54401373 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.54165455 |
| 27 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.51575531 |
| 28 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.48738853 |
| 29 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.48027108 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.47853192 |
| 31 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.46873176 |
| 32 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.43998105 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41229634 |
| 34 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.41064362 |
| 35 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.40846852 |
| 36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.40525064 |
| 37 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.38818040 |
| 38 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.36567332 |
| 39 | * EOMES_21245162_ChIP-Seq_HESCs_Human | 1.36526139 |
| 40 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.35629352 |
| 41 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.35629352 |
| 42 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.34844605 |
| 43 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.33319109 |
| 44 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.31956124 |
| 45 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.31616100 |
| 46 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.31253376 |
| 47 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31220111 |
| 48 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.30789928 |
| 49 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.30748048 |
| 50 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30158861 |
| 51 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.29445969 |
| 52 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.28518417 |
| 53 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.28462854 |
| 54 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.28462854 |
| 55 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.28229291 |
| 56 | GATA1_19941826_ChIP-Seq_K562_Human | 1.27185453 |
| 57 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.26869060 |
| 58 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.25874994 |
| 59 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.25675819 |
| 60 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.22871984 |
| 61 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.22763545 |
| 62 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22323410 |
| 63 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.22093964 |
| 64 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.22093964 |
| 65 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.22093964 |
| 66 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.22082190 |
| 67 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22052074 |
| 68 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.21981631 |
| 69 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.21564347 |
| 70 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.20001893 |
| 71 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.19324383 |
| 72 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.18652467 |
| 73 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.16443541 |
| 74 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14791935 |
| 75 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.14688651 |
| 76 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.14602866 |
| 77 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.14388603 |
| 78 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12745198 |
| 79 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.11298612 |
| 80 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.10855342 |
| 81 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.10695322 |
| 82 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.09666428 |
| 83 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.09483437 |
| 84 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09310114 |
| 85 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.09089113 |
| 86 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.08980969 |
| 87 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.08692230 |
| 88 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.08467831 |
| 89 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.07767009 |
| 90 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.07316242 |
| 91 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04058571 |
| 92 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.04023842 |
| 93 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03971837 |
| 94 | * TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.02456696 |
| 95 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.02376115 |
| 96 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.02376115 |
| 97 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.02106098 |
| 98 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.01899245 |
| 99 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.01828724 |
| 100 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01745730 |
| 101 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01669735 |
| 102 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01321318 |
| 103 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.99768135 |
| 104 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98838832 |
| 105 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.96609755 |
| 106 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96595148 |
| 107 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.95892362 |
| 108 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95667613 |
| 109 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.95533297 |
| 110 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.95379363 |
| 111 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.95040149 |
| 112 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.94571311 |
| 113 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.93629391 |
| 114 | SPI1_23127762_ChIP-Seq_K562_Human | 0.93587035 |
| 115 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.93523904 |
| 116 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.92771041 |
| 117 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.92292872 |
| 118 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.92254685 |
| 119 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92151745 |
| 120 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.91371108 |
| 121 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.91186727 |
| 122 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.91014489 |
| 123 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.90942079 |
| 124 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.90738759 |
| 125 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.90544386 |
| 126 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.89680883 |
| 127 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.89374802 |
| 128 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.89216008 |
| 129 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88567768 |
| 130 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.87890029 |
| 131 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.87851716 |
| 132 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.87385570 |
| 133 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.86854533 |
| 134 | KDM2B_26808549_Chip-Seq_K562_Human | 0.86830650 |
| 135 | * CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.86210266 |
| 136 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84355479 |
| 137 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.83630181 |
| 138 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.83013629 |
| 139 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81674111 |
| 140 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.81044558 |
| 141 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.80947041 |
| 142 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.80082371 |
| 143 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.79763903 |
| 144 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.79676885 |
| 145 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.79258127 |
| 146 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.78395817 |
| 147 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.78295539 |
| 148 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.77061285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.23628984 |
| 2 | MP0000920_abnormal_myelination | 3.96152534 |
| 3 | MP0003566_abnormal_cell_adhesion | 3.70091090 |
| 4 | MP0005464_abnormal_platelet_physiology | 3.68006064 |
| 5 | MP0005410_abnormal_fertilization | 3.51285410 |
| 6 | MP0008004_abnormal_stomach_pH | 3.35346699 |
| 7 | MP0003690_abnormal_glial_cell | 3.32492225 |
| 8 | MP0003329_amyloid_beta_deposits | 3.23184786 |
| 9 | MP0003950_abnormal_plasma_membrane | 3.07417654 |
| 10 | MP0003878_abnormal_ear_physiology | 2.71780882 |
| 11 | MP0005377_hearing/vestibular/ear_phenot | 2.71780882 |
| 12 | MP0009840_abnormal_foam_cell | 2.68540720 |
| 13 | MP0004272_abnormal_basement_membrane | 2.65504999 |
| 14 | MP0005623_abnormal_meninges_morphology | 2.62828131 |
| 15 | MP0003634_abnormal_glial_cell | 2.46046761 |
| 16 | MP0009384_cardiac_valve_regurgitation | 2.35398086 |
| 17 | MP0004885_abnormal_endolymph | 2.25575665 |
| 18 | MP0005257_abnormal_intraocular_pressure | 2.23170859 |
| 19 | MP0001958_emphysema | 2.11515131 |
| 20 | MP0002295_abnormal_pulmonary_circulatio | 2.05853677 |
| 21 | MP0005058_abnormal_lysosome_morphology | 2.02782085 |
| 22 | MP0000604_amyloidosis | 2.00986230 |
| 23 | MP0002653_abnormal_ependyma_morphology | 2.00529946 |
| 24 | MP0000465_gastrointestinal_hemorrhage | 1.85121863 |
| 25 | MP0003806_abnormal_nucleotide_metabolis | 1.83571768 |
| 26 | MP0008995_early_reproductive_senescence | 1.82680641 |
| 27 | MP0003941_abnormal_skin_development | 1.82165544 |
| 28 | MP0003279_aneurysm | 1.78054081 |
| 29 | MP0003011_delayed_dark_adaptation | 1.76501443 |
| 30 | MP0003195_calcinosis | 1.74906575 |
| 31 | MP0000639_abnormal_adrenal_gland | 1.68877059 |
| 32 | MP0003632_abnormal_nervous_system | 1.66313299 |
| 33 | MP0004858_abnormal_nervous_system | 1.65855963 |
| 34 | MP0005503_abnormal_tendon_morphology | 1.60088455 |
| 35 | MP0004036_abnormal_muscle_relaxation | 1.57427149 |
| 36 | MP0005647_abnormal_sex_gland | 1.51494948 |
| 37 | MP0003186_abnormal_redox_activity | 1.47554086 |
| 38 | MP0005275_abnormal_skin_tensile | 1.46544075 |
| 39 | MP0001661_extended_life_span | 1.42602788 |
| 40 | MP0003172_abnormal_lysosome_physiology | 1.40035269 |
| 41 | MP0005365_abnormal_bile_salt | 1.39701635 |
| 42 | MP0002254_reproductive_system_inflammat | 1.36481790 |
| 43 | MP0005083_abnormal_biliary_tract | 1.32498495 |
| 44 | MP0002132_abnormal_respiratory_system | 1.32224971 |
| 45 | MP0000858_altered_metastatic_potential | 1.30138386 |
| 46 | MP0003303_peritoneal_inflammation | 1.28825316 |
| 47 | MP0005670_abnormal_white_adipose | 1.27317791 |
| 48 | MP0006054_spinal_hemorrhage | 1.26727161 |
| 49 | MP0000767_abnormal_smooth_muscle | 1.25775823 |
| 50 | MP0004084_abnormal_cardiac_muscle | 1.23929248 |
| 51 | MP0009278_abnormal_bone_marrow | 1.22875793 |
| 52 | MP0003828_pulmonary_edema | 1.20713363 |
| 53 | MP0001542_abnormal_bone_strength | 1.20294117 |
| 54 | MP0006138_congestive_heart_failure | 1.20262035 |
| 55 | MP0000343_altered_response_to | 1.19252095 |
| 56 | MP0003724_increased_susceptibility_to | 1.18162857 |
| 57 | MP0004134_abnormal_chest_morphology | 1.17983365 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 1.17919206 |
| 59 | MP0004233_abnormal_muscle_weight | 1.17789648 |
| 60 | MP0000751_myopathy | 1.17374108 |
| 61 | MP0004147_increased_porphyrin_level | 1.16989848 |
| 62 | MP0005595_abnormal_vascular_smooth | 1.15900153 |
| 63 | MP0010030_abnormal_orbit_morphology | 1.14670751 |
| 64 | MP0005171_absent_coat_pigmentation | 1.12355837 |
| 65 | MP0001485_abnormal_pinna_reflex | 1.11410129 |
| 66 | MP0003436_decreased_susceptibility_to | 1.10918371 |
| 67 | MP0001929_abnormal_gametogenesis | 1.10703256 |
| 68 | MP0003075_altered_response_to | 1.10435404 |
| 69 | MP0003698_abnormal_male_reproductive | 1.08133640 |
| 70 | MP0003942_abnormal_urinary_system | 1.07403903 |
| 71 | MP0000749_muscle_degeneration | 1.06951798 |
| 72 | MP0000747_muscle_weakness | 1.06203664 |
| 73 | MP0001533_abnormal_skeleton_physiology | 1.03820409 |
| 74 | MP0010678_abnormal_skin_adnexa | 1.03162185 |
| 75 | MP0003300_gastrointestinal_ulcer | 1.02688014 |
| 76 | MP0003191_abnormal_cellular_cholesterol | 1.01735233 |
| 77 | MP0002168_other_aberrant_phenotype | 1.01619588 |
| 78 | MP0003091_abnormal_cell_migration | 1.01282871 |
| 79 | MP0002090_abnormal_vision | 1.00654920 |
| 80 | MP0000383_abnormal_hair_follicle | 0.98288057 |
| 81 | MP0004130_abnormal_muscle_cell | 0.97945731 |
| 82 | MP0005508_abnormal_skeleton_morphology | 0.97289878 |
| 83 | MP0005451_abnormal_body_composition | 0.95527426 |
| 84 | MP0000647_abnormal_sebaceous_gland | 0.95283290 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 0.95226058 |
| 86 | MP0010329_abnormal_lipoprotein_level | 0.93513033 |
| 87 | MP0002139_abnormal_hepatobiliary_system | 0.93002227 |
| 88 | MP0005165_increased_susceptibility_to | 0.92664279 |
| 89 | MP0004087_abnormal_muscle_fiber | 0.89887485 |
| 90 | MP0000462_abnormal_digestive_system | 0.89759980 |
| 91 | MP0001851_eye_inflammation | 0.89515570 |
| 92 | MP0005390_skeleton_phenotype | 0.89419136 |
| 93 | MP0000249_abnormal_blood_vessel | 0.89058420 |
| 94 | MP0002210_abnormal_sex_determination | 0.88389952 |
| 95 | MP0005248_abnormal_Harderian_gland | 0.87486216 |
| 96 | MP0005666_abnormal_adipose_tissue | 0.87419095 |
| 97 | MP0001145_abnormal_male_reproductive | 0.87369254 |
| 98 | MP0005367_renal/urinary_system_phenotyp | 0.87021514 |
| 99 | MP0000516_abnormal_urinary_system | 0.87021514 |
| 100 | MP0003631_nervous_system_phenotype | 0.86912175 |
| 101 | MP0003045_fibrosis | 0.86421466 |
| 102 | MP0005319_abnormal_enzyme/_coenzyme | 0.86411143 |
| 103 | MP0000534_abnormal_ureter_morphology | 0.83576388 |
| 104 | MP0003448_altered_tumor_morphology | 0.83311765 |
| 105 | MP0003221_abnormal_cardiomyocyte_apopto | 0.83191179 |
| 106 | MP0001915_intracranial_hemorrhage | 0.82302758 |
| 107 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.81944348 |
| 108 | MP0005332_abnormal_amino_acid | 0.80643509 |
| 109 | MP0005397_hematopoietic_system_phenotyp | 0.79782035 |
| 110 | MP0001545_abnormal_hematopoietic_system | 0.79782035 |
| 111 | MP0004019_abnormal_vitamin_homeostasis | 0.79216337 |
| 112 | MP0003115_abnormal_respiratory_system | 0.79032362 |
| 113 | MP0005164_abnormal_response_to | 0.78656474 |
| 114 | MP0003705_abnormal_hypodermis_morpholog | 0.78473878 |
| 115 | MP0005621_abnormal_cell_physiology | 0.78262730 |
| 116 | MP0005084_abnormal_gallbladder_morpholo | 0.77404733 |
| 117 | MP0004742_abnormal_vestibular_system | 0.76924300 |
| 118 | MP0000428_abnormal_craniofacial_morphol | 0.76654827 |
| 119 | MP0000733_abnormal_muscle_development | 0.76272117 |
| 120 | MP0000653_abnormal_sex_gland | 0.76225544 |
| 121 | MP0002972_abnormal_cardiac_muscle | 0.76164597 |
| 122 | MP0005501_abnormal_skin_physiology | 0.75713199 |
| 123 | MP0009763_increased_sensitivity_to | 0.75640045 |
| 124 | MP0001243_abnormal_dermal_layer | 0.74217497 |
| 125 | MP0001727_abnormal_embryo_implantation | 0.74069499 |
| 126 | MP0002249_abnormal_larynx_morphology | 0.73173637 |
| 127 | MP0005023_abnormal_wound_healing | 0.73154537 |
| 128 | MP0008877_abnormal_DNA_methylation | 0.72903240 |
| 129 | MP0002118_abnormal_lipid_homeostasis | 0.72820622 |
| 130 | MP0000230_abnormal_systemic_arterial | 0.72689080 |
| 131 | MP0002998_abnormal_bone_remodeling | 0.71843234 |
| 132 | MP0001849_ear_inflammation | 0.71684605 |
| 133 | MP0004883_abnormal_blood_vessel | 0.71590724 |
| 134 | MP0000467_abnormal_esophagus_morphology | 0.71521749 |
| 135 | MP0002229_neurodegeneration | 0.70367556 |
| 136 | MP0010630_abnormal_cardiac_muscle | 0.70365286 |
| 137 | MP0003795_abnormal_bone_structure | 0.70363740 |
| 138 | MP0001614_abnormal_blood_vessel | 0.69166200 |
| 139 | MP0001905_abnormal_dopamine_level | 0.68131281 |
| 140 | MP0003453_abnormal_keratinocyte_physiol | 0.68059063 |
| 141 | MP0002128_abnormal_blood_circulation | 0.67959657 |
| 142 | MP0010368_abnormal_lymphatic_system | 0.66326254 |
| 143 | MP0001175_abnormal_lung_morphology | 0.66209869 |
| 144 | MP0008260_abnormal_autophagy | 0.66141022 |
| 145 | MP0000750_abnormal_muscle_regeneration | 0.65968879 |
| 146 | MP0008789_abnormal_olfactory_epithelium | 0.65296418 |
| 147 | MP0005330_cardiomyopathy | 0.64889172 |
| 148 | MP0000598_abnormal_liver_morphology | 0.64215354 |
| 149 | MP0001544_abnormal_cardiovascular_syste | 0.63924256 |
| 150 | MP0005375_adipose_tissue_phenotype | 0.62915806 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 5.74572253 |
| 2 | Petechiae (HP:0000967) | 5.47212449 |
| 3 | Increased mean platelet volume (HP:0011877) | 5.06878842 |
| 4 | Gonadal dysgenesis (HP:0000133) | 5.05179412 |
| 5 | Purpura (HP:0000979) | 4.97180735 |
| 6 | Abnormal platelet volume (HP:0011876) | 4.82037152 |
| 7 | Menorrhagia (HP:0000132) | 4.78621255 |
| 8 | Prolonged bleeding time (HP:0003010) | 4.46160159 |
| 9 | Male infertility (HP:0003251) | 4.04990322 |
| 10 | Cerebral inclusion bodies (HP:0100314) | 4.01525884 |
| 11 | Gingival bleeding (HP:0000225) | 3.93446202 |
| 12 | Clumsiness (HP:0002312) | 3.58957128 |
| 13 | Cervical subluxation (HP:0003308) | 3.52390945 |
| 14 | Premature rupture of membranes (HP:0001788) | 3.50238683 |
| 15 | Gonadotropin excess (HP:0000837) | 3.49173496 |
| 16 | Broad metatarsal (HP:0001783) | 3.42483536 |
| 17 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.42465282 |
| 18 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.42465282 |
| 19 | Protrusio acetabuli (HP:0003179) | 3.41223952 |
| 20 | Stridor (HP:0010307) | 3.36542309 |
| 21 | Abnormal gallbladder physiology (HP:0012438) | 3.26818150 |
| 22 | Cholecystitis (HP:0001082) | 3.26818150 |
| 23 | Mesangial abnormality (HP:0001966) | 3.26172349 |
| 24 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.25303953 |
| 25 | Epistaxis (HP:0000421) | 3.24116349 |
| 26 | Diaphragmatic weakness (HP:0009113) | 3.12594664 |
| 27 | Ankle clonus (HP:0011448) | 3.04715922 |
| 28 | Increased cerebral lipofuscin (HP:0011813) | 2.97665697 |
| 29 | Onion bulb formation (HP:0003383) | 2.96391945 |
| 30 | Vascular tortuosity (HP:0004948) | 2.95953335 |
| 31 | Premature skin wrinkling (HP:0100678) | 2.93030769 |
| 32 | Megalencephaly (HP:0001355) | 2.90323367 |
| 33 | Abnormal sex determination (HP:0012244) | 2.87785415 |
| 34 | Sex reversal (HP:0012245) | 2.87785415 |
| 35 | Abnormality of dentin (HP:0010299) | 2.87479453 |
| 36 | Synostosis involving the elbow (HP:0003938) | 2.87448765 |
| 37 | Humeroradial synostosis (HP:0003041) | 2.87448765 |
| 38 | Loss of speech (HP:0002371) | 2.85128954 |
| 39 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.84134852 |
| 40 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.84051422 |
| 41 | Hyporeflexia of lower limbs (HP:0002600) | 2.82802884 |
| 42 | Supranuclear gaze palsy (HP:0000605) | 2.75538490 |
| 43 | Nuclear cataract (HP:0100018) | 2.72759744 |
| 44 | Axonal loss (HP:0003447) | 2.70701895 |
| 45 | Arterial tortuosity (HP:0005116) | 2.69600052 |
| 46 | Hypoplastic pelvis (HP:0008839) | 2.68746007 |
| 47 | Aortic dissection (HP:0002647) | 2.68335817 |
| 48 | Systemic lupus erythematosus (HP:0002725) | 2.65592392 |
| 49 | Ankle contracture (HP:0006466) | 2.63026967 |
| 50 | Myocardial infarction (HP:0001658) | 2.58378361 |
| 51 | Peripheral hypomyelination (HP:0007182) | 2.56783481 |
| 52 | Renal salt wasting (HP:0000127) | 2.56464520 |
| 53 | Abnormal platelet function (HP:0011869) | 2.53632517 |
| 54 | Impaired platelet aggregation (HP:0003540) | 2.53632517 |
| 55 | Abnormal auditory evoked potentials (HP:0006958) | 2.50263711 |
| 56 | Bladder diverticulum (HP:0000015) | 2.50196245 |
| 57 | Parakeratosis (HP:0001036) | 2.49945227 |
| 58 | Hepatosplenomegaly (HP:0001433) | 2.48584730 |
| 59 | Coronal craniosynostosis (HP:0004440) | 2.48318899 |
| 60 | Vacuolated lymphocytes (HP:0001922) | 2.48185084 |
| 61 | Hypoplasia of the iris (HP:0007676) | 2.45833277 |
| 62 | Hypoplasia of the uterus (HP:0000013) | 2.45771833 |
| 63 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.44971457 |
| 64 | Aplasia of the phalanges of the hand (HP:0009802) | 2.44971457 |
| 65 | Aplasia involving bones of the extremities (HP:0009825) | 2.44971457 |
| 66 | Hypoplastic left heart (HP:0004383) | 2.38495873 |
| 67 | Mitral stenosis (HP:0001718) | 2.35088082 |
| 68 | Exercise-induced muscle cramps (HP:0003710) | 2.33194859 |
| 69 | Shallow orbits (HP:0000586) | 2.32566312 |
| 70 | Prolonged neonatal jaundice (HP:0006579) | 2.32266802 |
| 71 | Tetraparesis (HP:0002273) | 2.31166876 |
| 72 | Insidious onset (HP:0003587) | 2.28791232 |
| 73 | Termporal pattern (HP:0011008) | 2.28791232 |
| 74 | Hyperlipoproteinemia (HP:0010980) | 2.25263991 |
| 75 | Dysostosis multiplex (HP:0000943) | 2.24599288 |
| 76 | Pulmonary artery stenosis (HP:0004415) | 2.23462116 |
| 77 | Hypoalphalipoproteinemia (HP:0003233) | 2.21601770 |
| 78 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.20210097 |
| 79 | Increased circulating renin level (HP:0000848) | 2.20045014 |
| 80 | Abnormality of the corticospinal tract (HP:0002492) | 2.19800357 |
| 81 | Testicular neoplasm (HP:0010788) | 2.18814582 |
| 82 | Distal upper limb amyotrophy (HP:0007149) | 2.18365777 |
| 83 | Upper limb amyotrophy (HP:0009129) | 2.18365777 |
| 84 | Hyperglycinemia (HP:0002154) | 2.12687679 |
| 85 | Dilatation of the ascending aorta (HP:0005111) | 2.12385420 |
| 86 | Gowers sign (HP:0003391) | 2.12212771 |
| 87 | Abnormality of glycolipid metabolism (HP:0010969) | 2.11816914 |
| 88 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.11816914 |
| 89 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.11816914 |
| 90 | Joint hemorrhage (HP:0005261) | 2.11548125 |
| 91 | Intrahepatic cholestasis (HP:0001406) | 2.11299955 |
| 92 | Difficulty running (HP:0009046) | 2.10932102 |
| 93 | Amyloidosis (HP:0011034) | 2.09714687 |
| 94 | Abnormality of the common coagulation pathway (HP:0010990) | 2.09044403 |
| 95 | Abnormality of glycine metabolism (HP:0010895) | 2.08929415 |
| 96 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.08929415 |
| 97 | Abnormality of macrophages (HP:0004311) | 2.07390819 |
| 98 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.06197142 |
| 99 | Spinal rigidity (HP:0003306) | 2.05593672 |
| 100 | Muscle fiber splitting (HP:0003555) | 2.04673999 |
| 101 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.04429579 |
| 102 | Mucopolysacchariduria (HP:0008155) | 2.04429579 |
| 103 | Blue sclerae (HP:0000592) | 2.03570631 |
| 104 | Wormian bones (HP:0002645) | 2.02359163 |
| 105 | Bell-shaped thorax (HP:0001591) | 2.01692000 |
| 106 | Infantile muscular hypotonia (HP:0008947) | 2.01658189 |
| 107 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.00157239 |
| 108 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.00157239 |
| 109 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.00157239 |
| 110 | Hypoglycemic seizures (HP:0002173) | 1.97839813 |
| 111 | Abnormal delivery (HP:0001787) | 1.97074553 |
| 112 | Abnormality of the anterior horn cell (HP:0006802) | 1.95935666 |
| 113 | Degeneration of anterior horn cells (HP:0002398) | 1.95935666 |
| 114 | Sensory axonal neuropathy (HP:0003390) | 1.95664301 |
| 115 | Male pseudohermaphroditism (HP:0000037) | 1.94710903 |
| 116 | Retinal dysplasia (HP:0007973) | 1.94612554 |
| 117 | Episodic fever (HP:0001954) | 1.94428209 |
| 118 | Peripheral demyelination (HP:0011096) | 1.92808706 |
| 119 | Soft skin (HP:0000977) | 1.90664894 |
| 120 | Bruising susceptibility (HP:0000978) | 1.89052671 |
| 121 | Cholelithiasis (HP:0001081) | 1.88898926 |
| 122 | Bronchomalacia (HP:0002780) | 1.87569353 |
| 123 | Polycythemia (HP:0001901) | 1.86489626 |
| 124 | Pterygium (HP:0001059) | 1.86139001 |
| 125 | Aortic aneurysm (HP:0004942) | 1.86121240 |
| 126 | Intention tremor (HP:0002080) | 1.85909903 |
| 127 | Turricephaly (HP:0000262) | 1.85378275 |
| 128 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.85345334 |
| 129 | Infertility (HP:0000789) | 1.84476840 |
| 130 | Clonus (HP:0002169) | 1.80316296 |
| 131 | Arachnodactyly (HP:0001166) | 1.79478351 |
| 132 | Increased variability in muscle fiber diameter (HP:0003557) | 1.78812951 |
| 133 | Cerebral hemorrhage (HP:0001342) | 1.78193162 |
| 134 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.77619424 |
| 135 | Peritonitis (HP:0002586) | 1.77007734 |
| 136 | Neonatal short-limb short stature (HP:0008921) | 1.76768003 |
| 137 | Hemorrhage of the eye (HP:0011885) | 1.76652700 |
| 138 | Follicular hyperkeratosis (HP:0007502) | 1.76410113 |
| 139 | Abolished electroretinogram (ERG) (HP:0000550) | 1.76364050 |
| 140 | Large for gestational age (HP:0001520) | 1.75594807 |
| 141 | Abnormal gallbladder morphology (HP:0012437) | 1.74688758 |
| 142 | Hypercholesterolemia (HP:0003124) | 1.74503937 |
| 143 | Spastic paraparesis (HP:0002313) | 1.73510315 |
| 144 | Back pain (HP:0003418) | 1.73447791 |
| 145 | Generalized amyotrophy (HP:0003700) | 1.73181897 |
| 146 | Vertebral hypoplasia (HP:0008417) | 1.72493272 |
| 147 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.72493272 |
| 148 | Vertebral compression fractures (HP:0002953) | 1.70458658 |
| 149 | Biconcave vertebral bodies (HP:0004586) | 1.70215645 |
| 150 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.69585436 |
| 151 | Osteolytic defects of the hand bones (HP:0009699) | 1.69585436 |
| 152 | Venous insufficiency (HP:0005293) | 1.67904895 |
| 153 | Aneurysm (HP:0002617) | 1.66989999 |
| 154 | Xanthomatosis (HP:0000991) | 1.65907440 |
| 155 | Spastic gait (HP:0002064) | 1.64789458 |
| 156 | Hypoplasia of the odontoid process (HP:0003311) | 1.64309446 |
| 157 | Esophageal atresia (HP:0002032) | 1.64046638 |
| 158 | Femoral bowing (HP:0002980) | 1.63974091 |
| 159 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.63594166 |
| 160 | Hypoplastic heart (HP:0001961) | 1.63571577 |
| 161 | Hyperextensible skin (HP:0000974) | 1.63310094 |
| 162 | Hand muscle atrophy (HP:0009130) | 1.63251453 |
| 163 | Partial duplication of thumb phalanx (HP:0009944) | 1.63250490 |
| 164 | Deep venous thrombosis (HP:0002625) | 1.62999464 |
| 165 | Abnormality of the acetabulum (HP:0003170) | 1.62735560 |
| 166 | Ovoid vertebral bodies (HP:0003300) | 1.62617488 |
| 167 | Exercise-induced myalgia (HP:0003738) | 1.62586854 |
| 168 | Alacrima (HP:0000522) | 1.62272841 |
| 169 | Calcaneovalgus deformity (HP:0001848) | 1.61880881 |
| 170 | Neuronal loss in central nervous system (HP:0002529) | 1.61826432 |
| 171 | Hydroxyprolinuria (HP:0003080) | 1.61072885 |
| 172 | Abnormality of proline metabolism (HP:0010907) | 1.61072885 |
| 173 | Hypophosphatemic rickets (HP:0004912) | 1.58971997 |
| 174 | Atrophic scars (HP:0001075) | 1.58635828 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.10828708 |
| 2 | EPHB1 | 4.03706571 |
| 3 | NEK9 | 2.91391949 |
| 4 | MAPKAPK5 | 2.79489399 |
| 5 | ICK | 2.77081836 |
| 6 | TRIB3 | 2.68166984 |
| 7 | LIMK1 | 2.56173691 |
| 8 | PRKD3 | 2.51479393 |
| 9 | MET | 2.39959550 |
| 10 | TYRO3 | 2.24656659 |
| 11 | LMTK2 | 2.14464381 |
| 12 | WNK4 | 2.11984334 |
| 13 | OXSR1 | 2.06595273 |
| 14 | MAP3K3 | 1.97052890 |
| 15 | TESK1 | 1.92329600 |
| 16 | EPHA2 | 1.88929734 |
| 17 | EIF2AK1 | 1.86764475 |
| 18 | PDK3 | 1.72533136 |
| 19 | PDK4 | 1.72533136 |
| 20 | TAOK2 | 1.64638516 |
| 21 | SIK1 | 1.55964600 |
| 22 | FGFR4 | 1.55611831 |
| 23 | ROCK2 | 1.55104011 |
| 24 | TESK2 | 1.53954790 |
| 25 | MAP2K3 | 1.52131739 |
| 26 | NTRK1 | 1.51967891 |
| 27 | PDK2 | 1.43507089 |
| 28 | FGFR2 | 1.40661035 |
| 29 | TRPM7 | 1.40080022 |
| 30 | BCKDK | 1.38815798 |
| 31 | MUSK | 1.36592021 |
| 32 | PAK6 | 1.36066977 |
| 33 | WNK1 | 1.34408343 |
| 34 | STK38 | 1.32115335 |
| 35 | MYLK | 1.31280455 |
| 36 | LRRK2 | 1.30498896 |
| 37 | ILK | 1.28572710 |
| 38 | EEF2K | 1.26932183 |
| 39 | PRKG2 | 1.26142969 |
| 40 | KSR2 | 1.25114987 |
| 41 | TAOK1 | 1.23902558 |
| 42 | PHKG1 | 1.23772128 |
| 43 | PHKG2 | 1.23772128 |
| 44 | PKN1 | 1.22894033 |
| 45 | ARAF | 1.22585009 |
| 46 | PAK3 | 1.21896402 |
| 47 | PIM2 | 1.21407480 |
| 48 | ERN1 | 1.20462421 |
| 49 | CSNK1A1L | 1.20339502 |
| 50 | BMX | 1.19901676 |
| 51 | SIK3 | 1.19281063 |
| 52 | PBK | 1.18079136 |
| 53 | RIPK1 | 1.17202478 |
| 54 | VRK2 | 1.15880616 |
| 55 | MAP3K1 | 1.13463138 |
| 56 | DDR2 | 1.13435287 |
| 57 | CDK19 | 1.13281497 |
| 58 | PAK2 | 1.12799579 |
| 59 | PTK2B | 1.12282765 |
| 60 | TBK1 | 1.09785028 |
| 61 | MATK | 1.09686494 |
| 62 | ZAP70 | 1.09659199 |
| 63 | ABL2 | 1.08609404 |
| 64 | DMPK | 1.07404809 |
| 65 | MAP2K2 | 1.07362610 |
| 66 | PTK2 | 1.07198897 |
| 67 | MAP3K5 | 1.03273839 |
| 68 | PTK6 | 1.00711530 |
| 69 | MAP3K11 | 0.99828235 |
| 70 | PAK4 | 0.96079852 |
| 71 | MAP4K2 | 0.95628432 |
| 72 | CSNK1G3 | 0.94990059 |
| 73 | SGK494 | 0.94263575 |
| 74 | SGK223 | 0.94263575 |
| 75 | KIT | 0.91599307 |
| 76 | PRKD1 | 0.90229100 |
| 77 | PRPF4B | 0.87569344 |
| 78 | IRAK3 | 0.86975270 |
| 79 | MOS | 0.85995120 |
| 80 | PDGFRA | 0.83748634 |
| 81 | FLT3 | 0.82663690 |
| 82 | DAPK3 | 0.82612731 |
| 83 | BCR | 0.82568196 |
| 84 | DYRK1B | 0.79621333 |
| 85 | DYRK3 | 0.79534783 |
| 86 | EPHA3 | 0.78615774 |
| 87 | MAPK15 | 0.78412561 |
| 88 | PAK1 | 0.77945361 |
| 89 | ROCK1 | 0.76356610 |
| 90 | EIF2AK3 | 0.73107808 |
| 91 | ERBB4 | 0.72574900 |
| 92 | KDR | 0.68898196 |
| 93 | NEK6 | 0.63814365 |
| 94 | CAMK2D | 0.62777545 |
| 95 | CSNK1G1 | 0.62540175 |
| 96 | SMG1 | 0.61696992 |
| 97 | DYRK2 | 0.60861274 |
| 98 | CSF1R | 0.59062073 |
| 99 | IRAK1 | 0.58921313 |
| 100 | TTN | 0.57799144 |
| 101 | LATS1 | 0.57203634 |
| 102 | YES1 | 0.56071127 |
| 103 | EPHB2 | 0.55370850 |
| 104 | CAMK2G | 0.55093593 |
| 105 | TNK2 | 0.53910494 |
| 106 | CDC42BPA | 0.53637329 |
| 107 | RPS6KA2 | 0.53588073 |
| 108 | CDK9 | 0.52796834 |
| 109 | TYK2 | 0.51217670 |
| 110 | TIE1 | 0.50379044 |
| 111 | MAP3K12 | 0.49813469 |
| 112 | RAF1 | 0.49785991 |
| 113 | HIPK2 | 0.49737794 |
| 114 | MAPKAPK3 | 0.49046764 |
| 115 | PDGFRB | 0.48689875 |
| 116 | FER | 0.48377116 |
| 117 | CDK8 | 0.48159236 |
| 118 | CSNK1G2 | 0.47536021 |
| 119 | PINK1 | 0.46985778 |
| 120 | RET | 0.46038434 |
| 121 | NME2 | 0.45376063 |
| 122 | TGFBR2 | 0.44650998 |
| 123 | CAMK1D | 0.44126506 |
| 124 | MAPKAPK2 | 0.43886139 |
| 125 | GSK3A | 0.43626800 |
| 126 | MTOR | 0.42114691 |
| 127 | MAPK7 | 0.41737586 |
| 128 | SRC | 0.41315151 |
| 129 | SGK3 | 0.41041140 |
| 130 | PKN2 | 0.40839503 |
| 131 | PRKACB | 0.40816664 |
| 132 | SCYL2 | 0.40808772 |
| 133 | MST4 | 0.40660197 |
| 134 | MARK2 | 0.39911871 |
| 135 | HCK | 0.39778006 |
| 136 | CDK14 | 0.39322092 |
| 137 | MAP3K8 | 0.38588302 |
| 138 | LATS2 | 0.38315789 |
| 139 | CDK7 | 0.38250826 |
| 140 | PRKD2 | 0.37638045 |
| 141 | TNIK | 0.37285977 |
| 142 | PLK2 | 0.37136976 |
| 143 | FGR | 0.36616083 |
| 144 | ERBB2 | 0.36544783 |
| 145 | GRK6 | 0.35879431 |
| 146 | FES | 0.35807140 |
| 147 | STK3 | 0.34439881 |
| 148 | UHMK1 | 0.32845240 |
| 149 | MAP2K1 | 0.31869173 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 4.28626892 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.18311843 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.36537913 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.29549216 |
| 5 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.19877808 |
| 6 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.84765442 |
| 7 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.58412350 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.46275450 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.21745062 |
| 10 | Galactose metabolism_Homo sapiens_hsa00052 | 2.20835305 |
| 11 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.15053991 |
| 12 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.09297171 |
| 13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.07744662 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.05430353 |
| 15 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.94686872 |
| 16 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.81737293 |
| 17 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.79927994 |
| 18 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.79121249 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.79031328 |
| 20 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.76190922 |
| 21 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.70051058 |
| 22 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.69647551 |
| 23 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.65639451 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.55636199 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.51892462 |
| 26 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.51858768 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.48352054 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.45138373 |
| 29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.39281439 |
| 30 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.38607699 |
| 31 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.28666051 |
| 32 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.27441515 |
| 33 | Lysosome_Homo sapiens_hsa04142 | 1.26773763 |
| 34 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.24232766 |
| 35 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.22405886 |
| 36 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.21039410 |
| 37 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.18009383 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.17635491 |
| 39 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.13579858 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 1.11331127 |
| 41 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.09413534 |
| 42 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.08511770 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.07900881 |
| 44 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.06697073 |
| 45 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.04907897 |
| 46 | Mineral absorption_Homo sapiens_hsa04978 | 1.00852844 |
| 47 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.98692151 |
| 48 | Focal adhesion_Homo sapiens_hsa04510 | 0.97121279 |
| 49 | Proteasome_Homo sapiens_hsa03050 | 0.96799487 |
| 50 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.96765804 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.94535286 |
| 52 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.93926419 |
| 53 | Tight junction_Homo sapiens_hsa04530 | 0.93203867 |
| 54 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.91257677 |
| 55 | Peroxisome_Homo sapiens_hsa04146 | 0.90615265 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87745293 |
| 57 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.87671246 |
| 58 | Amoebiasis_Homo sapiens_hsa05146 | 0.84612911 |
| 59 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.83201467 |
| 60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.81810471 |
| 61 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.79029795 |
| 62 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.78458357 |
| 63 | Malaria_Homo sapiens_hsa05144 | 0.76753328 |
| 64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.74499046 |
| 65 | Carbon metabolism_Homo sapiens_hsa01200 | 0.74289314 |
| 66 | Axon guidance_Homo sapiens_hsa04360 | 0.72863795 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72047649 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71587696 |
| 69 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70486856 |
| 70 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.68890498 |
| 71 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.68610504 |
| 72 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.64992008 |
| 73 | Shigellosis_Homo sapiens_hsa05131 | 0.64862234 |
| 74 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.64544828 |
| 75 | Bile secretion_Homo sapiens_hsa04976 | 0.64399586 |
| 76 | Endocytosis_Homo sapiens_hsa04144 | 0.64334021 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63201832 |
| 78 | Adherens junction_Homo sapiens_hsa04520 | 0.62823022 |
| 79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.60691311 |
| 80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.60385173 |
| 81 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.59939940 |
| 82 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.59543306 |
| 83 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.58753087 |
| 84 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.58266846 |
| 85 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.57459413 |
| 86 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56846943 |
| 87 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.56250071 |
| 88 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.55151952 |
| 89 | Protein export_Homo sapiens_hsa03060 | 0.54740744 |
| 90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54718609 |
| 91 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.54176991 |
| 92 | Bladder cancer_Homo sapiens_hsa05219 | 0.54117675 |
| 93 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.53788694 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53740886 |
| 95 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.53343802 |
| 96 | Retinol metabolism_Homo sapiens_hsa00830 | 0.53317151 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51334545 |
| 98 | Legionellosis_Homo sapiens_hsa05134 | 0.49981720 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49627622 |
| 100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.49043722 |
| 101 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.48626548 |
| 102 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.48417445 |
| 103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46975001 |
| 104 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.46649611 |
| 105 | Phagosome_Homo sapiens_hsa04145 | 0.46159827 |
| 106 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.44751243 |
| 107 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.44414700 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44309621 |
| 109 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.43612474 |
| 110 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41989974 |
| 111 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40145748 |
| 112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.39430692 |
| 113 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.37162037 |
| 114 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.37142410 |
| 115 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.36536022 |
| 116 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.35287639 |
| 117 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.35036219 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34236277 |
| 119 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.33593248 |
| 120 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.32454092 |
| 121 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.31314595 |
| 122 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.31257594 |
| 123 | Pathways in cancer_Homo sapiens_hsa05200 | 0.30833194 |
| 124 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.30786033 |
| 125 | Pertussis_Homo sapiens_hsa05133 | 0.30601556 |
| 126 | Salmonella infection_Homo sapiens_hsa05132 | 0.30562642 |
| 127 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.29819782 |
| 128 | Prion diseases_Homo sapiens_hsa05020 | 0.29502189 |
| 129 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28444108 |
| 130 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.27783174 |
| 131 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.27656529 |
| 132 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.26560179 |
| 133 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.26094923 |
| 134 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.25546485 |
| 135 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.25397405 |

